Why I’d buy this share for the recovery after this bear market

Strong figures today and a five-year record of growth. I’m watching this share like a hawk!

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Despite posting some decent figures in today’s half-year report, the ventilation products maker Volution (LSE: FAN) share price is weak this morning.

I reckon news flow surrounding the coronavirus is driving this stock lower. In the outlook statement, the firm said measures governments are taking to control the evolving pandemic are creating “significant” uncertainty. The directors reckon there’ll likely be a “material impact” on the global economy. That implies a hit to trading, because there’s a large element of cyclicality to the Volution business.

Trading well in H2 so far

Although it’s hard to forecast, management believes there’s potential for adverse impacts on both supply and demand for the company. But there is “limited” sales exposure to some of the hardest-hit countries such as China, Italy and South Korea. Meanwhile, the firm is taking actions to “monitor and secure” its supply chain.

And things are going well so far. In the second half of the trading year, performance has continued “on a similar basis” to the first half.  And several new product launches could boost sales over the next few months.

Looking beyond the current macro-economic challenges, the lead directors think regulatory drivers are “increasingly supportive” of energy-efficient ventilation solutions. This could augur well for the business over the medium term.

Prior to the crisis, Volution had been growing well. The five-year record is one of generally rising revenue, earnings, cash flow and shareholder dividends. And today’s numbers are impressive. In the first half of the trading year to 31 January, revenue at constant currency rates rose 5% compared to the equivalent period the prior year. In terms of the adjusted figures, operating cash flow shot up almost 44% and earnings per share moved 6.5% higher.

Net debt lower

There was also good news regarding net debt, which dropped by almost 14% to just over £60m on a like-for-like basis. I’m pleased to see progress with lowering debt because if trading conditions get tough, the firm will need its interest payments to be as low as possible.

The directors slapped 6.9% on the interim dividend, which suggests there’s a measure of confidence in the outlook, despite the pandemic. Meanwhile, one of the things I admire about Volution is the way operations are growing geographically. In H1, 46% of sales came from the UK, 30% from Europe (excluding the UK and Sweden), 13% from Australasia, 9% from Sweden and 2% from the rest of the world.

I’m not going to try to pin down the valuation on this one until there are clear signs that the share price has ended its plunge. But this is high up my watch list, and I’d be keen to examine it in more detail later with a view to picking up a few of the shares.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »